Fulminant Transverse Myelitis and Reversible Cerebral Vasculopathy in an Aquaporin-4-Antibody Positive Patient With Active Systemic Lupus Erythematosus (2622)
作者
David Gritsch,Amir Abdallah,Brian W. Chong,Marie Francisca Grill,Dean M. Wingerchuk
出处
期刊:Neurology [Lippincott Williams & Wilkins] 日期:2020-04-14卷期号:94 (15_supplement)
标识
DOI:10.1212/wnl.94.15_supplement.2622
摘要
Objective: NA Background: Aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disease (NMOSD) may coexist with systemic lupus erythematosus (SLE). Vasculopathy and/or vasculitis are pathophysiologic mechanisms implicated in neuropsychiatric SLE (NPSLE). The pathophysiologic relationship between these disorders is currently unclear. Design/Methods: Case report. Results: A 27 year-old woman with a 10-year history of SLE treated with mycophenolate mofetil developed rapidly progressive quadriparesis with arreflexia, a thoracic sensory level, and urinary retention over 36 hours. Her symptoms started six days earlier with fever, headaches, pruritic skin eruptions, nausea, vomiting and back spasms. Spinal MRI showed extensive T2-weighted signal abnormality involving the entire cord from the conus to the lower medulla. Cerebrospinal fluid analysis revealed lymphocytic predominant pleocytosis (152 WBC/mcl, 85% lymphocytes). Laboratory testing revealed low serum complement levels and positive titers for ANA, SSA, and dsDNA; AQP4-IgG was positive at a titer of > 1:100,000. Myelin oligodendrocyte glycoprotein (MOG) and antiphospholipid antibodies were negative. Skin biopsy demonstrated leukocytoclastic vasculitis. MRI brain demonstrated scattered, nonenhancing T2 hyperintensities in the deep subcortical white matter, brainstem and cerebellum and a punctate periventricular infarct. Brain MR angiography (MRA) showed segmental narrowing and dilation involving medium and small sized vessels. Treatment was initiated with intravenous methylprednisolone and cyclophosphamide followed by rituximab. Repeat brain MRA on hospital day 5 showed significant improvement in the appearance of the intracranial vasculature; her rash and headache resolved but minimal motor recovery was noted. Conclusions: This AQP4-IgG seropositive patient with SLE experienced concomitant longitudinally extensive myelitis, cutaneous vasculitis, and reversible intracranial vasculopathy. Observations of the timing of treatment response implicates multiple potential pathophysiologic mechanisms of tissue injury and vascular involvement. Co-occurrence of NMOSD and NPSLE poses significant diagnostic and therapeutic challenges. Disclosure: Dr. Gritsch has nothing to disclose. Dr. Abdallah has nothing to disclose. Dr. Chong has nothing to disclose. Dr. Grill has nothing to disclose. Dr. Wingerchuk has received personal compensation from BrainStorm Therapeutics, Caladrius Biosciences, Celgene, Chugai Pharmaceutical, MedImmune, Novartis, ONO Pharma-ceutical, Viela Bio. Dr. Wingerchuk has received personal compensation in an editorial capacity for OXP. Dr. Wingerchuk has received research support from Alexion Pharmaceuticals, Terumo BCT.